NantHealth to Present & Exhibit on the Convergence of Precision Medicine & Value-Based Care at America’s Health Insurance P...
June 19 2018 - 8:01PM
Business Wire
NantHealth (NASDAQ: NH), a next-generation healthcare
company, will exhibit and present at America’s Health Insurance
Plans (AHIP) Institute & Expo 2018 taking place June 20-22,
2018 at the San Diego Convention Center in San Diego, CA at booth
#824.
NantHealth, a Silver-Sponsor at the AHIP Institute & Expo
2018, will showcase its health IT and precision medicine solutions,
including NaviNet®, Eviti®, GPS Cancer, and Liquid GPS® at booth
#824.
NantHealth will present “Demystifying the
Convergence of Precision Medicine and Value-Based Care” at a
Breakfast Briefing in Room 33AB on Thursday, June 21, 2018 at 7:15
AM Pacific Time. Presenters Dr. Sandeep
“Bobby” Reddy, Chief Medical Officer, and Kristin Lee, VP of Payer Sales and Client
Engagement, will highlight the challenges and opportunities
posed by precision medicine and value-based care and how health
plans can navigate their convergence.
NantHealth representatives will also exhibit NaviNet, Eviti, GPS
Cancer, and Liquid GPS.
- NaviNet
Open® is a secure, multi-payer platform that lets health
plans and providers exchange vital administrative and clinical
information in real-time, improving communications between health
plans and their provider networks.
- Eviti®
Connect streamlines the pre-authorization of cancer
treatment through the online entry of treatment
plans, eliminating phone calls to health plans, while reducing
denials and appeals.
- GPS
Cancer® is a precise and comprehensive tissue-based
molecular profile that integrates tumor-normal sequencing of DNA
with RNA sequencing, providing oncologists with insights they
can rely on to inform personalized treatment strategies.
- Liquid GPS™ is a
blood-based molecular test that provides oncologists with a
powerful tool for noninvasive tumor profiling and quantitative
monitoring of treatment response. Liquid GPS looks beyond cfDNA to
cfRNA, which allows profiling and trending of actionable biomarkers
that cannot be assessed through cfDNA alone.
“NantHealth is thrilled to showcase its health IT and precision
medicine solutions at AHIP 2018,” said Dr. Bobby Reddy, CMO of
NantHealth. “I am personally excited to discuss NantHealth’s
perspective regarding the intrinsic link between precision medicine
and value-based care and how health plans can navigate their
convergence.” Attend our Breakfast Briefing in Room 33AB and
visit NantHealth in the Exhibit Hall at booth #824 to view
NaviNet, Eviti, and GPS demos.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of
companies, is a next-generation, evidence-based, personalized
healthcare company enabling improved patient outcomes and more
effective treatment decisions for critical illnesses. NantHealth’s
focused portfolio exemplifies its unique systems-based approach to
personalized healthcare and integrates novel diagnostics with
large-scale, biometric and phenotypic data to track patient
outcomes and deliver precision medicine. For more information,
please visit www.nanthealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180619006502/en/
NantWorksJen Hodsonjhodson@nantworks.com
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Mar 2024 to Apr 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Apr 2023 to Apr 2024